Document is current
Any future updates will be listed below
-
Authors
Eto, Futoshi
Nezu, Tomohisa
Nishi, Hiromi
Aoki, Shiro
Tasaka, Saki
Horikoshi, Susumu
Yano, Kanako
Kawaguchi, Hiroyuki
Maruyama, Hirofumi
-
Funding
Funding for this research was provided by:
Hiroshima University
- License Information
-
More Information
Article History
Received: 24 February 2024
Accepted: 14 July 2024
First Online: 19 July 2024
Declarations
:
: Tomohisa Nezu received Grants-in-Aid for Scientific Research (20K16579). Shiro Aoki received Grants-in-Aid for Scientific Research (21K10210). Hirofumi Maruyama received Grants-in-Aid for Scientific Research (23H02827) and research support from Eisai, Takeda Pharmaceutical, Otsuka Pharmaceutical, Nihon Pharmaceutical, Shionogi, Teijin Pharma, Fuji Film, Sumitomo Pharma, Nihon Medi-Physics, Daiichi Sankyo, Kyowa Kirin, Sanofi, Novartis, Tsumura, Japan Blood Products Organization, Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, and Viatris, all of which are unrelated to the submitted work.The other authors report no conflicts of interest.
: This study followed the Declaration of Helsinki and was approved by the ethics committees at Hiroshima University, including the institutional review board (approval number E2017‒856).
